Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Bittner

Showing results (121-130 of 269) with videos related to

Pageof 27
Sort By:
Journal of the American College of Cardiology|April 12, 2008
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 29, 2024
Death, long-term nursing home placement, and impoverishment after recurrent myocardial infarctionEmily B Levitan, Bharat Poudel, Lei Huang, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|June 15, 2007
Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary RehabilitationGary J Balady, Mark A Williams, Philip A Ades, et al.
Journal of the American College of Cardiology|November 7, 2015
The role of the clinical pharmacist in the care of patients with cardiovascular diseaseSteven P Dunn, Kim K Birtcher, Craig J Beavers, et al.
BMC Health Services Research|May 1, 2014
Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional studyEvan L Thacker, Paul Muntner, Hong Zhao, et al.
Circulation. Population Health and Outcomes|March 2, 2026
Barriers and Emerging Strategies to Bridge Gaps in Implementation of Evidence-Based Lipid-Lowering TherapiesChristopher S Marnell, Wolfgang Koenig, Vera Bittner, et al.
Journal of the American College of Cardiology|August 14, 2015
Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D TrialVera Bittner, Marnie Bertolet, Rafael Barraza Felix, et al.
Circulation|June 26, 2002
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)David M Herrington, Eric Vittinghoff, Feng Lin, et al.
Menopause (New York, N.Y.)|August 27, 2015
Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis StudyChrisandra Shufelt, Omeed Elboudwarej, B Delia Johnson, et al.
Pageof 27

Showing results (121-130 of 269) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|April 12, 2008
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 29, 2024
Death, long-term nursing home placement, and impoverishment after recurrent myocardial infarctionEmily B Levitan, Bharat Poudel, Lei Huang, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|June 15, 2007
Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary RehabilitationGary J Balady, Mark A Williams, Philip A Ades, et al.
Journal of the American College of Cardiology|November 7, 2015
The role of the clinical pharmacist in the care of patients with cardiovascular diseaseSteven P Dunn, Kim K Birtcher, Craig J Beavers, et al.
BMC Health Services Research|May 1, 2014
Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional studyEvan L Thacker, Paul Muntner, Hong Zhao, et al.
Circulation. Population Health and Outcomes|March 2, 2026
Barriers and Emerging Strategies to Bridge Gaps in Implementation of Evidence-Based Lipid-Lowering TherapiesChristopher S Marnell, Wolfgang Koenig, Vera Bittner, et al.
Journal of the American College of Cardiology|August 14, 2015
Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D TrialVera Bittner, Marnie Bertolet, Rafael Barraza Felix, et al.
Circulation|June 26, 2002
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)David M Herrington, Eric Vittinghoff, Feng Lin, et al.
Menopause (New York, N.Y.)|August 27, 2015
Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis StudyChrisandra Shufelt, Omeed Elboudwarej, B Delia Johnson, et al.
Pageof 27